Global CBD markets are under pressure after the European Commission (EC) asserted that CBD extracts from hemp flowers aren’t valid for approval under the Novel Foods policy. A spokesperson for the EC said primary concern lies with “CBD extracted from the flowering and fruiting tops of the hemp plant (Cannabis sativa)”. The European Commission has “informed the applicants of its preliminary views and invited them to provide comments”, the spokesperson added. This includes 50 applicants from a number of countries, including the US.
Czech based CBDepot submitted their application for synthetic CBD to the European Food Safety Authority (EFSA) in November of last year. On March 31, CBDepot’s application for registering synthesized trans-CBD as a ‘Novel Food’ substance appeared as EC Mandate# M-2018-0021 on EFSA’s Register of Questions portal:
…
01.22.2025
Be8, Cemvita to study glycerin-to-SAF feasibility in Brazil
Brazilian biofuels producer Be8 and US-based biotech company Cemvita signed a memorandum of understanding to study the technical and economic feasibility of converting glycerin into sustainable aviation fuel (SAF),...
01.22.2025
CWG prices jump 17% from prior week on strong renewable demand
The choice white grease (CWG) market continued to trade higher on Wednesday January 22 with deals done as high as 42 cents per lb FOB Missouri River, but the...
01.22.2025
US weekly wheat, soybean export inspections decline; corn up 7%
Export inspections of US grains showed a decline for soybean and wheat, while corn increased in the week to January 16, according to data from the USDA released on...